JPS5888385A - 7-oxa-2-azabicyclo(2,2,1)hept-2-ene derivative and its preparation - Google Patents

7-oxa-2-azabicyclo(2,2,1)hept-2-ene derivative and its preparation

Info

Publication number
JPS5888385A
JPS5888385A JP56186558A JP18655881A JPS5888385A JP S5888385 A JPS5888385 A JP S5888385A JP 56186558 A JP56186558 A JP 56186558A JP 18655881 A JP18655881 A JP 18655881A JP S5888385 A JPS5888385 A JP S5888385A
Authority
JP
Japan
Prior art keywords
oxa
solvent
azabicyclo
ene
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56186558A
Other languages
Japanese (ja)
Other versions
JPH0216318B2 (en
Inventor
Sadakatsu Shimada
嶋田 定勝
Toshiaki Tojo
東條 俊明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP56186558A priority Critical patent/JPS5888385A/en
Publication of JPS5888385A publication Critical patent/JPS5888385A/en
Publication of JPH0216318B2 publication Critical patent/JPH0216318B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

NEW MATERIAL:The comound of formulaI[R1 and R3 are H or lower alkyl; when X is -CO-, then Y is -NR2- (R2 is H, lower alkyl, phenyl, or aralkyl) and Z is -CH2-, and when X is -NR2-, then Y is -CO- and Z is -O-]. EXAMPLE:10-Methyl-2-oxo-3-phenyl -11- oxa-3, 9-diazatricyclo[6,2,1,0<1>,<6>]-undec- 9-ene. USE:Synthetic intermediates for pharmaceuticals, dyes, etc. PROCESS:The compound of formulaIcan be prepared by heating the oxazole derivative of formula II[e.g. N-(3-butenyl)-4-methyloxazole-5-carboxylic acid anilide]in a solvent such as o-xylene at the boiling point of the solvent.

Description

【発明の詳細な説明】 本発明は一般式(I) (式中島および亀は各々独立して水素原子または低級ア
ルキル基を、Xは−CO−または−NR1−を意味−し
、xが−co−ノときYは−N%−テZは−CHz−を
意味し、またXが−NRz−のときYは−CO−で2は
一〇−を意味する。ここで烏は水素原子、低級アルキル
基、7!ニル基またはアラルキル基を意味する。)で表
わされる7−オキサ−8−アザビシクロ(2,!、l 
)へブタ−2−エン誘導体およびその製法に関するもの
である。
Detailed Description of the Invention The present invention is based on the general formula (I) (Formula Nakajima and Kame each independently represent a hydrogen atom or a lower alkyl group, X means -CO- or -NR1-, and x represents - When co-no, Y means -N%-teZ means -CHz-, and when X is -NRz-, Y means -CO- and 2 means 10-.Here, crow is a hydrogen atom, 7-oxa-8-azabicyclo (2,!, l means lower alkyl group, 7!nyl group or aralkyl group)
) Hebut-2-ene derivatives and their production methods.

更に詳しくは1本発明は分子内にオレフィンを持ったオ
キサゾール誘導体を加熱することにより、7−オキサ−
2−アザビシク’ (”*s+1)へブタ−2−エン誘
導体を製造する方法およびかくして得られる新規化合物
に関する。
More specifically, 1 the present invention produces 7-oxa-
The present invention relates to a method for producing 2-azabisic'("*s+1) but-2-ene derivatives and to novel compounds thus obtained.

従来、7−オキサ−!−アザビシクロ(B、2.1)へ
ブタ−2−エン誘導体を製造するにはオキサゾール類と
ジェノフィルを分子間で反応させる方法が知られている
。しかし、この方法ではオキサゾール類とジェノフィル
の反応性が強い場合にのみ反応し、オキサゾール類とジ
ェノフィルの反応性が小さい場合には目的物が得られな
い。
Conventionally, 7-oxa-! -Azabicyclo(B, 2.1) To produce a but-2-ene derivative, a method is known in which oxazoles and Genophile are reacted intermolecularly. However, in this method, the reaction occurs only when the reactivity of the oxazole and Genophile is strong, and the target product cannot be obtained when the reactivity of the oxazole and Genophile is small.

例えば、オキサゾール−5−カルボン酸エステルをH−
アリルアニリンと分子間反応で反応しても付加反応は起
こらない。またオキサゾ−/L’−6−1ルバミン酸エ
ステルヲクロトニールアルコールと分子間で反応させて
も7−オキサ−2−アザビシクロ(Z、!、1)へブタ
−2−エン類は全く得られない。
For example, oxazole-5-carboxylic acid ester is
Even if it reacts with allylaniline through an intermolecular reaction, no addition reaction occurs. Furthermore, even if oxazo-/L'-6-1 rubamate ester is reacted intermolecularly with crotonyl alcohol, no but-2-enes can be obtained from 7-oxa-2-azabicyclo(Z,!,1). do not have.

本発明者等は7−オキサ−2−アザビシクロ(1,2,
1) ヘ2$ −@−エン誘導体の製法について鋭意検
討した結果、オレフィンを酸アミド結合によってオキサ
ゾール分子と結合させ、オキサゾール分子内に固定する
ことにより極めて容易に、かつ高収率で目的物が得られ
ることを見出し本発明を完成した。
The present inventors have discovered that 7-oxa-2-azabicyclo (1,2,
1) As a result of intensive studies on the method for producing H2$-@-ene derivatives, we found that the desired product could be obtained extremely easily and in high yield by bonding an olefin to an oxazole molecule through an acid amide bond and fixing it within the oxazole molecule. They found that it can be obtained and completed the present invention.

即ち、オキサゾール分子とオレフィンをエステル結合に
よって結合させたオキサゾール−5−力ルボン酸アリー
ルエステルの場合は加熱しても付加反応が全く起こらな
いが、オキサゾールとオレフィンを単に分子内に固定す
るだけではなく1両者を酸アミド結合で結合させること
によって始めて本発明の目的物が得られるのである。こ
こでの酸アミドは2級アミドでも反応は進行するが、酸
アミドのアミノ基にアルキル基、78ニル基あるいはア
ラルキル基を導入した3級アミドの方が好ましい。
In other words, in the case of oxazole-5-carboxylic acid aryl ester, in which an oxazole molecule and an olefin are bonded together through an ester bond, no addition reaction occurs at all even when heated; 1. The object of the present invention can only be obtained by bonding both of them through an acid amide bond. Although the reaction proceeds even if the acid amide is a secondary amide, a tertiary amide in which an alkyl group, 78yl group, or aralkyl group is introduced into the amino group of the acid amide is preferable.

本発明化合物(1)は次式の方法によって製造される。The compound (1) of the present invention is produced by the method of the following formula.

(式中R1,R3,X、 Yおよび2は前記と同じ。)
即ち2本発明反応は、一般にディールス−アルダ−反応
に使用される溶媒中で8式(1)で示されるオキサゾー
ルを、使用溶媒の一点まで加熱することによって進行す
るが、無溶媒で行なうこともできる。使用溶媒としては
9例えばベンゼン、トルエン、キシレン等の炭化水素類
や。
(In the formula, R1, R3, X, Y and 2 are the same as above.)
That is, the reaction of the present invention generally proceeds by heating the oxazole represented by formula (1) in a solvent used in the Diels-Alder reaction to a point in the solvent used, but it can also be carried out without a solvent. can. Examples of solvents used include hydrocarbons such as benzene, toluene, and xylene.

ジオキサン、イソプロピルエーテル等のエーテル類、ジ
メチルホルムアミド等のアミド類の他アセトニトリル、
クロロホルム等が挙げられる。
Ethers such as dioxane and isopropyl ether, amides such as dimethylformamide, acetonitrile,
Examples include chloroform.

また9反応液から式(りの目的物を単離するには使用溶
媒を留去し、析出した結晶を濾取すれば良いが、場合に
よっては脱色、再結晶、りpマドグラフィー等1通常の
方法で精製を行なっても良い。
In addition, in order to isolate the target product of the formula (9) from the reaction solution, the solvent used can be distilled off and the precipitated crystals can be collected by filtration, but depending on the case, decolorization, recrystallization, lipomatography, etc. Purification may be carried out by the following method.

尚1本発明に使用される原料化合物(1)はオキサゾー
ル類とオレフィンを酸アミード結合により結合させるこ
とにより容易に合成し得−る。例えば、オキサゾール−
5−カルボン酸クロライドとアルケニルアミンを反応さ
せることによりオキサゾール−5−カルボン酸アルケニ
ルアミドが得られる。また、オキサゾール−5−イソシ
アナートとアルケニルアルコールを反応させることによ
りオキサゾール−5−カルバミン酸アルケニルエステル
を得ることが出来る。更にこのものは常法により1例え
ばアルキル化剤を用いて対応するN−アルキルオキサゾ
ール−器−カルバミン酸アルケニルエステルへと誘導で
きる。この様にして合成したオキサゾール−5−カルダ
ン酸アルケニルアミド、N−アルキルオキサゾール−5
−カルバミン酸アルケニルエステル等は一般的に無色の
油状物である。
Note that the raw material compound (1) used in the present invention can be easily synthesized by bonding an oxazole and an olefin through an acid amide bond. For example, oxazole-
Oxazole-5-carboxylic acid alkenylamide is obtained by reacting 5-carboxylic acid chloride with alkenylamine. Further, oxazole-5-carbamic acid alkenyl ester can be obtained by reacting oxazole-5-isocyanate and alkenyl alcohol. Furthermore, this compound can be converted into the corresponding N-alkyloxazole-carbamic acid alkenyl ester in a conventional manner using, for example, an alkylating agent. Oxazole-5-cardanoic acid alkenylamide synthesized in this way, N-alkyloxazole-5
- Carbamic acid alkenyl esters etc. are generally colorless oils.

かくして製される本発明化合物の7−オキサ−2−□ア
ザビシクロ(t、2.1)へブタ−2−エン誘導体は、
水のみまたは水および酸の存在下加熱すると7ラン誘導
体へ、酸のみの存在下加熱するとフェノール誘導体へ、
あるいは不活性溶媒中加熱するとピリジン誘導体へ容易
に導くことができるので、医薬品、染料、その他の合成
中間体として有用である。
The 7-oxa-2-□azabicyclo(t, 2.1)hebut-2-ene derivative of the present compound thus produced is:
Heating in the presence of water alone or water and acid gives a 7-ran derivative; heating in the presence of acid alone gives a phenol derivative;
Alternatively, it can be easily converted into a pyridine derivative by heating in an inert solvent, making it useful as a synthetic intermediate for pharmaceuticals, dyes, and others.

以下実施例および参考例によって本発明を説明する。The present invention will be explained below with reference to Examples and Reference Examples.

°実施例1 N−(8−ブテニル)−4−メチルオキすゾール−5−
カルボン酸アニリド5.09に0−キシレン170−を
加え34時間加熱還流する。
°Example 1 N-(8-butenyl)-4-methyloxazole-5-
0-xylene 170- is added to 5.09 g of carboxylic acid anilide and heated under reflux for 34 hours.

反応液より溶媒を留去後、アルミナカラムクロマトグラ
フィーに付し、酢酸エチルにて溶出。
After distilling off the solvent from the reaction solution, it was subjected to alumina column chromatography and eluted with ethyl acetate.

精製すると無色油状物として10−メチル−2−オキソ
−8−フェニル−11−オキサ−8,9−ジアザトリシ
クロ(e、 L I? ”シロ〕ウンデカー9−エン1
.B 89 (25,6%)を得る。尚、原料オキサゾ
ール1.629(82,4%)を回収する。
Purification yields 10-methyl-2-oxo-8-phenyl-11-oxa-8,9-diazatricyclo(e, L I?'cylo) undec-9-ene 1 as a colorless oil.
.. Obtaining B 89 (25,6%). Note that 1.629 (82.4%) of raw material oxazole was recovered.

IRy””cm−’  :  1 6 5 0. 1 
6 20x NMR(CDC13)δ: s−1s (s Hl g + −N−CCah )1
.60〜L@ 0 (5H,ya、 −0HzCklG
Hx−)8.70 (@H,*、 −N−0旦zOHt
−)5.85 (IH,6,J−8,0H1,−〇−’
pa >?、80 (5H,ss、 arom、 I(
)実施例2 N−(8−ブテニル)−2,4−ジメチルオキサゾール
−5−カルボン酸アニリド6.4−を0−キシレン中6
日間加熱還流後、実施例1と同様に処理し、8.10−
ジメチル−2−オキソ−8−7!ニル−11−オキサ−
3,9−ジアザトリジクリ(6,Ll、0い〕ウンデカ
−9−エン4.111(64,1%)を得る。無色微細
針状晶。
IRy""cm-': 1 6 5 0. 1
6 20x NMR (CDC13) δ: s-1s (s Hl g + -N-CCah)1
.. 60~L@0 (5H,ya, -0HzCklG
Hx-)8.70 (@H, *, -N-0danzOHt
-) 5.85 (IH, 6, J-8, 0H1, -〇-'
pa>? , 80 (5H,ss, arom, I(
) Example 2 N-(8-butenyl)-2,4-dimethyloxazole-5-carboxylic acid anilide 6.4- in 0-xylene
After heating under reflux for one day, the same treatment as in Example 1 was carried out, and 8.10-
Dimethyl-2-oxo-8-7! Nyl-11-oxa-
3,9-diazatridicry(6,Ll,0)undec-9-ene 4.111 (64.1%) is obtained as colorless fine needles.

融点1@6〜186℃0 実施例3 ドーメチルー4−メチルオキサゾール−5−力ルパミン
酸z−プロペニルエステルIJ69(0,01モル)に
0−キシレン200−を加え34時間加熱還流する。溶
媒を減圧下留去し残液に適量のイソプロピルエーテルを
加え析出結晶を濾取するとz、10−ジメチル−3−オ
キソ−4,11−ジオキサ−3,9−ジアザトリシクロ
(6,111,O’+’ )ウンデカ−e−エンt、e
sp(88襲)を得る。融点114℃。
Melting point 1@6-186°C0 Example 3 0-xylene 200- was added to domethyl-4-methyloxazole-5-lupamic acid z-propenyl ester IJ69 (0.01 mol) and heated under reflux for 34 hours. The solvent was distilled off under reduced pressure, an appropriate amount of isopropyl ether was added to the residual liquid, and the precipitated crystals were collected by filtration to give z,10-dimethyl-3-oxo-4,11-dioxa-3,9-diazatricyclo(6,111,O'+' ) undec-e-ent, e
Obtain sp (88 attacks). Melting point: 114°C.

実施例4 N−ベンジル−4−メチルオキサゾール−5−カルパミ
ン1I2−プ(ベニルエステル1.7110、oxそル
)を実施例3と同様に反応および処理し、2−ベンジル
−1O−メチル−8−オキソ−4,11−ジオキサ−2
,9−ジアザトリシクロ(6,2,1,g”−)ウンデ
カ−9−エンLSO181%)を得る。融点170℃。
Example 4 N-benzyl-4-methyloxazole-5-carpamine 1I2-p (benyl ester 1.7110, oxol) was reacted and treated in the same manner as in Example 3 to give 2-benzyl-1O-methyl-8 -oxo-4,11-dioxa-2
,9-diazatricyclo(6,2,1,g''-)undec-9-ene LSO 181%), melting point 170°C.

実施例5 N−ベンジル−4−メチルオキサゾール−5−カルバミ
ン酸z−ブテニルエステル1.4B9(0,005モル
)を実施例3と同条件下71時間加熱還流し、以下実施
例Bと同様処理すると2−ベンジル−7、lO−ジメチ
ル−8−オキソ−4,11−ジオキサ−2,9−ジアザ
トリシクロ(612,1,O1w@ )ウンデカ−9−
エン0.609(42%)を得る。融点15!’C0 実施例6 N−ベンジル−2,4−ジメチルオキサゾール−b−力
ルバミン酸z−プロペニルエステル3.86り(0,0
1モル)を実施例5と同様に処理し、3−ベンジル−8
,lO−ジメチル−3−オキソ−4,11−ジオキサ−
3,9−ジアザトリジl o (6J、l、O”−:l
ウンデカ−Q −x >Z、II9(74%)を得る。
Example 5 N-benzyl-4-methyloxazole-5-carbamic acid z-butenyl ester 1.4B9 (0,005 mol) was heated under reflux for 71 hours under the same conditions as in Example 3, and the same procedure as in Example B was carried out. Upon treatment, 2-benzyl-7,lO-dimethyl-8-oxo-4,11-dioxa-2,9-diazatricyclo(612,1,O1w@)undec-9-
0.609 (42%). Melting point 15! 'C0 Example 6 N-benzyl-2,4-dimethyloxazole-b-rubamic acid z-propenyl ester 3.86 (0,0
1 mol) was treated in the same manner as in Example 5 to give 3-benzyl-8
,lO-dimethyl-3-oxo-4,11-dioxa-
3,9-diazatridyl o (6J, l, O”-:l
undeca-Q −x >Z, yielding II9 (74%).

融点11S”C0実施例7 N−ベンジル−2,4−ジメチルオキサゾール−5−カ
ルバミン酸@−フチニルエステルを実施例6と同様に処
理し、!−ベンジルー?、8.10−トリメチル−8−
オキソ−4,11−ジオキす−3,9−ジアザトリジ9
0 (e、z、i、os+s )ウンデカ−9−エンを
得る。融点18fi’C6参考例1 3.4−ジメチルオキサゾール−5−カルボン酸6.4
89 (45,6gaol )にチオニルクロリドlo
ogtを加え4時間加熱還流する。過剰のチオニルクロ
リドを減圧下留去し、得られる残渣をベンゼン80−に
溶解する。N−(3−ブテニル)アニリン6.789 
(45,7101)をピリジン100−に溶解し、水冷
下先の−クロリドを滴下する。減圧下ピリジンを留去し
、1p4濠をクロロホルムに溶かし、飽和硫酸銅水溶液
Melting point 11S"C0 Example 7 N-benzyl-2,4-dimethyloxazole-5-carbamic acid@-futhynyl ester was treated in the same manner as in Example 6 to give !-benzyl?, 8.10-trimethyl-8-
Oxo-4,11-diox-3,9-diazatridi9
0 (e, z, i, os+s)undec-9-ene is obtained. Melting point 18fi'C6 Reference example 1 3.4-dimethyloxazole-5-carboxylic acid 6.4
89 (45,6 gaol) with thionyl chloride lo
Add ogt and heat under reflux for 4 hours. Excess thionyl chloride is distilled off under reduced pressure, and the resulting residue is dissolved in 80% of benzene. N-(3-butenyl)aniline 6.789
(45,7101) is dissolved in pyridine 100-, and -chloride is added dropwise while cooling with water. Pyridine was distilled off under reduced pressure, 1p4 moat was dissolved in chloroform, and a saturated aqueous copper sulfate solution was added.

IN塩酸水溶液、5%重ソウ水溶液にて洗浄し硫酸マグ
ネシウムにて乾燥する。りOaホルムを留去し得られる
残渣をシリカゲルを用いたカラムクロマトグラフィーに
て精製する。油状物12.099(98,2%)を得る
Wash with IN hydrochloric acid aqueous solution and 5% sodium chloride aqueous solution, and dry with magnesium sulfate. The Oa form is distilled off, and the resulting residue is purified by column chromatography using silica gel. 12.099 (98.2%) of oil are obtained.

参考例2 ソ 4−メチルオキサゾール−5−イサシアネー)11.4
Fをトルエン20@lに溶解し、アリルアルコールIO
gを徐々に加え混液を2時間100℃から110℃で加
熱する。反応終了後溶媒を留去し、残渣をシリカゲルを
用いたカラムクロマトグラフィーにて精製し、融点80
℃の4−メチルオキサゾール−5−カルバミン酸2−プ
ロペニルエステル15.51(855G)を得る。これ
を金属ナトリウム2.0F、メタノール100m/の混
液に溶解した後、溶媒を減圧で濃縮乾固する。濃縮残渣
にジメチルホルムアミド50−を加え、これにベンジル
クロリド11.0−を加え60℃から80℃にて80分
間加熱すδ。冷後反応液に水を加えエーテルで抽出し、
エーテル層を水洗、乾燥し溶媒を留去後残渣をシリカゲ
ルを用いたカラムクロマトグラフィーにて精製する。N
−ベンジル−4−メチルオキサゾール−5−カルバミン
酸3−プロペニルエステ/I/18.5F(77,4襲
)を油状瞼として得る。
Reference Example 2 So-4-methyloxazole-5-isacyane) 11.4
Dissolve F in 20@l of toluene and add allyl alcohol IO
g is gradually added and the mixture is heated at 100°C to 110°C for 2 hours. After the reaction, the solvent was distilled off, and the residue was purified by column chromatography using silica gel to obtain a melting point of 80.
15.51 (855G) of 4-methyloxazole-5-carbamic acid 2-propenyl ester are obtained. After dissolving this in a mixed solution of metallic sodium 2.0 F and methanol 100 m/l, the solvent was concentrated to dryness under reduced pressure. Dimethylformamide 50- is added to the concentrated residue, benzyl chloride 11.0- is added thereto, and the mixture is heated at 60°C to 80°C for 80 minutes δ. After cooling, water was added to the reaction solution and extracted with ether.
The ether layer is washed with water, dried, the solvent is distilled off, and the residue is purified by column chromatography using silica gel. N
-Benzyl-4-methyloxazole-5-carbamic acid 3-propenyl ester/I/18.5F (77,4 doses) is obtained as an oily eyelid.

参考例8 1G−メチル−Z−オキ/−1%−7,=ルー11−オ
キサ−8,9−ジアザトリシクロ(6,2゜101−)
ウンデカ−9−エンL、S 9 (5,5mmol)を
ジオキサン40gAt、水40@tの混液に溶解し1時
間半加熱還流する。冷後反応液より溶媒を留去し、得ら
れる残液を水にあけクロロホルムにて抽出する。クロロ
ホルム層を乾燥後、溶媒を留去し、2−ハイドロキシ−
7a−アセチル−6−7* ニル−8aH−ジヒドロ7
o(Z、21−C〕ピペリジン−7−オンのα体および
β体の混合峻16.4F(定量的)を淡黄色油状物とし
て得る。
Reference example 8 1G-methyl-Z-ox/-1%-7,=ru-11-oxa-8,9-diazatricyclo(6,2°101-)
Undec-9-ene L, S 9 (5.5 mmol) was dissolved in a mixture of 40 g of dioxane and 40@t of water, and heated under reflux for 1.5 hours. After cooling, the solvent is distilled off from the reaction mixture, and the resulting residual liquid is poured into water and extracted with chloroform. After drying the chloroform layer, the solvent was distilled off and 2-hydroxy-
7a-acetyl-6-7* nyl-8aH-dihydro7
16.4F (quantitative) of mixed α and β forms of o(Z, 21-C]piperidin-7-one is obtained as a pale yellow oil.

n5nt  −1 1RI/   c議 :@89Cj、1705,165
0,1680m&X Ms175(7%、M”)、25’1l(isチ)!、
RB(67%)、   282(100%)NMR(C
DOlj)δニー 1.50〜g、s o (5H,vs、 −a、!l!
20Hgh−、−毀且)II9.II0(合計8H,各
k s、 〜C0CHa )8.50〜4.oo (8
H,II、−NC仇C−61備−)5.70.5.76
 (合計IH,各々d、 J−4,0Hz、−Cji−
OH)’j、B S (5H,s、 arose、 H
)参考例4 8.10−ジメチル−2−オキソ−8−フェニル−11
−オキサ−8,9−ジアザトリシクロ(6,!、1.O
’、・〕〕ウンデカー9−エン1.5を〇−キシレン中
5日間加熱還流する。冷後減圧下溶媒を留去し残渣をシ
リカゲルを用いたクロマトグラフィーにて精製し、8−
メチル−1−オキソ−!−7Xニルピペリジノ(8,4
−(3)ピリジン0.989(70,8%)を得る。無
色微細針状晶、融点118〜180℃。
n5nt -1 1RI/c discussion: @89Cj, 1705,165
0,1680m&X Ms175 (7%, M"), 25'1l (ischi)!,
RB (67%), 282 (100%) NMR (C
DOlj) δ knee 1.50~g, s o (5H, vs, -a, !l!
20Hgh-, -disruption) II9. II0 (total 8H, each ks, ~C0CHa) 8.50-4. oo (8
H, II, -NC enemy C-61 equipment-) 5.70.5.76
(Total IH, each d, J-4, 0Hz, -Cji-
OH)'j, B S (5H,s, arose, H
) Reference Example 4 8.10-dimethyl-2-oxo-8-phenyl-11
-oxa-8,9-diazatricyclo(6,!, 1.O
',.]]Undec-9-ene 1.5 is heated under reflux in 0-xylene for 5 days. After cooling, the solvent was distilled off under reduced pressure, and the residue was purified by chromatography using silica gel.
Methyl-1-oxo-! -7X Nylpiperidino (8,4
-(3) 0.989 (70.8%) of pyridine is obtained. Colorless fine needle crystals, melting point 118-180°C.

Claims (1)

【特許請求の範囲】[Claims] (1)一般式 (式中R,お上びR3は各々独立して水素原子または低
級アルキル基を、Xは−GO−または−N1%−を意味
し、Xが一〇〇−(7)ときYは−N%−で2は−OH
,−を意味し、またXが−NR,−のときYは−CO−
て2は一〇−を意味する。ここで&は水素原子、低級ア
ルキル基、7!ニル基またはアラルキル基を意味する。 )で表わされるオキサゾール誘導体を加熱することを特
徴とする一般式 (式中R11Rs、 X、 Yおよび2は前記に同じ。 )で表わされる7−オキサ−2−アザビシクロ(S、2
.1 )へブタ−2−エン誘導体の製法。 (z)一般式 (式中R,および−は各々独立して水素原子または低級
アルキル基を、Xは−CO−または−N%−を意味し、
Xが−cO−のときYは−NR2−で2は−CH2−を
意味し、またXが−NR「のときYは−CO−で2は一
〇−を意味する。ここで島は水素原子、低級アルキル基
、フェニル基またはアラルキル基を意味する。)で表わ
される7−オキサ−2−アザビシクロ(t、2.1)へ
ブタ−2−エン誘導体。
(1) General formula (in the formula, R, and R3 each independently represent a hydrogen atom or a lower alkyl group, X means -GO- or -N1%-, and X is 100-(7) When Y is -N%- and 2 is -OH
,-, and when X is -NR,-, Y is -CO-
te 2 means 10-. Here & is a hydrogen atom, a lower alkyl group, 7! It means a nyl group or an aralkyl group. ) 7-oxa-2-azabicyclo (S, 2
.. 1) Method for producing hebut-2-ene derivatives. (z) General formula (in the formula, R and - each independently represent a hydrogen atom or a lower alkyl group, X means -CO- or -N%-,
When X is -cO-, Y is -NR2- and 2 means -CH2-, and when X is -NR', Y is -CO- and 2 means 10-.Here, the island is hydrogen atom, lower alkyl group, phenyl group or aralkyl group).
JP56186558A 1981-11-20 1981-11-20 7-oxa-2-azabicyclo(2,2,1)hept-2-ene derivative and its preparation Granted JPS5888385A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56186558A JPS5888385A (en) 1981-11-20 1981-11-20 7-oxa-2-azabicyclo(2,2,1)hept-2-ene derivative and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56186558A JPS5888385A (en) 1981-11-20 1981-11-20 7-oxa-2-azabicyclo(2,2,1)hept-2-ene derivative and its preparation

Publications (2)

Publication Number Publication Date
JPS5888385A true JPS5888385A (en) 1983-05-26
JPH0216318B2 JPH0216318B2 (en) 1990-04-16

Family

ID=16190620

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56186558A Granted JPS5888385A (en) 1981-11-20 1981-11-20 7-oxa-2-azabicyclo(2,2,1)hept-2-ene derivative and its preparation

Country Status (1)

Country Link
JP (1) JPS5888385A (en)

Also Published As

Publication number Publication date
JPH0216318B2 (en) 1990-04-16

Similar Documents

Publication Publication Date Title
DE69534300T2 (en) NEW MULTIMERIZING REAGENT
CH641154A5 (en) SUBSTITUTED HETEROCYCLIC BENZAMIDES.
St-Denis et al. Synthesis of 1-deoxycastanospermine and stereoisomers
Endo et al. Synthesis of 7-substituted indolactam-V: An introduction of hydrophobic moieties on the indole ring
GB1598667A (en) 1,3-dioxolane derivatives and their use in the preparation of 1-amino-3-aryloxy-2-propanols
JPS5888385A (en) 7-oxa-2-azabicyclo(2,2,1)hept-2-ene derivative and its preparation
WO2022104599A1 (en) N-heterocyclic carbene catalyst and preparation method therefor
JP3541952B2 (en) 4-arylisoindole analgesics
Endo et al. Synthesis and stereochemistry of indolactam congeners: Conformational behavior of the nine-membered lactams
JPS6051196A (en) 1-o-alkyl-3-amino-propan-1,2-diol-2-o-phospholipid and manufacture
CA2307748A1 (en) Aminomethyl-benzo[a]quinolizidine derivatives, preparation and therapeutic applications for neurodegenrative diseases
KR101155389B1 (en) New Process for the Synthesis of Ene-amide Deriverates
DE19853558A1 (en) Process for the preparation of 2,3-dihydroindoles (indolines), novel 2,3-dihydroindoles and their use
KR101521092B1 (en) Process for the preparation of arylamide and enamide derivatives using organic axide and iridium catalyst
KR102590897B1 (en) Method for producing chiral gamma-lactam compound and metal complex therefor
Alías et al. Synthesis of (S)-N-tert-butoxycarbonyl-N, O-isopropylidene-α-methylserinal: A potential building block for the asymmetric synthesis of non-natural amino acids
FR2901554A1 (en) 2-ALCOXY-3,4,5-TRIHYDROXY-ALKYLAMIDE-BENZAZEPINE, PREPARATION THEREOF, COMPOSITIONS CONTAINING SAME AND USE THEREOF
KR100383250B1 (en) Method for manufacturing n-(2-aminoethyl)-2-(3-pyridyl)-thiazolidin-4-one
CA2012342A1 (en) Platinum-derived complexes, their preparation and pharmaceutical compounds containing them
KR100284128B1 (en) Method for preparing 2,4,6-triiodobenzene derivative substituted with 1,3,5-position
KR101137503B1 (en) Process for the synthesis of histidyl-prolinamide derivatives using polymeric solid phase support
JPH02304090A (en) Preparation of polycyclic compound
JPH0499759A (en) (e)-2-alken-4-ynyl sulfonate derivative and production thereof
KR20010099122A (en) Resolution process for preparing l-muscone or d-muscone
Guoren et al. The Reaction of 1-Nitro-4-(4-nitrophenylsulfonylmethyl) benzene with α, β-Unsaturated Esters